A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Yale University
Genmab
H. Lee Moffitt Cancer Center and Research Institute
Cellectar Biosciences, Inc.
Gilead Sciences
University of Rochester
Acerta Pharma BV
Centre Antoine Lacassagne
University of Colorado, Denver
French Innovative Leukemia Organisation
Ryvu Therapeutics SA
Juventas Cell Therapy Ltd.
First Affiliated Hospital of Zhejiang University
University of Illinois at Chicago
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Beijing Boren Hospital
The First Affiliated Hospital of Soochow University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Maryland, Baltimore
Tarapeutics Science Inc.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
First Affiliated Hospital of Zhejiang University
BeiGene
Children's Hospital of Soochow University
University of California, San Diego
Changzhou Qianhong Bio-pharma Co., Ltd.
M.D. Anderson Cancer Center
Amgen
Tarapeutics Science Inc.
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Brown University
Arog Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
The First Affiliated Hospital of Soochow University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University Hospital Heidelberg
National Cancer Institute, Naples
Goethe University
Goethe University
BioSight Ltd.
KK Women's and Children's Hospital
SecuraBio
First Affiliated Hospital of Zhejiang University
Jewish General Hospital
AbbVie
Ludwig-Maximilians - University of Munich
University Hospital, Bordeaux